October 6, 2010
View Full PaperImpulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field
Key Points
Key points are not available for this paper at this time.
Abstract
Impulse control disorders among patients with Parkinson's disease receiving dopamine replacement therapy may provide a unique opportunity for addiction researchers to study the neurobiology of impulsive forms of behaviour (such as problem gambling) that appear to be caused, in part, by the therapeutic use of dopamine receptor agonists.